Spondylocostal dysplasia dominant
Spondylocostal dysplasia, dominant (SCD), also known as Jarcho-Levin syndrome when presenting in its severe form, is a rare genetic disorder characterized by abnormal development of the vertebrae and ribs. The condition is part of a group of disorders known as congenital skeletal dysplasias, which affect the shape and structure of the bones. Spondylocostal dysplasia can lead to a short trunk, scoliosis (curvature of the spine), and abnormalities in the rib cage, which can affect breathing.
Causes[edit | edit source]
Spondylocostal dysplasia, dominant, is caused by mutations in specific genes that are involved in the development of the spine and ribs during embryonic growth. The most commonly implicated gene in the dominant form of the condition is DLL3, although mutations in other genes such as MESP2, LFNG, and HES7 have been associated with the recessive forms of spondylocostal dysplasia. The disorder is inherited in an autosomal dominant pattern, meaning a mutation in just one of the two copies of the gene is sufficient to cause the disorder.
Symptoms[edit | edit source]
The symptoms of SCD can vary significantly from person to person but generally include:
- Abnormal curvature of the spine (scoliosis or kyphosis)
- Short trunk, compared to the limbs
- Abnormalities in the number and shape of ribs and vertebrae
- Possible respiratory difficulties due to reduced thoracic capacity
Diagnosis[edit | edit source]
Diagnosis of spondylocostal dysplasia is primarily based on physical examination and imaging studies such as X-rays, which can reveal the characteristic abnormalities in the spine and ribs. Genetic testing can confirm the diagnosis by identifying a mutation in one of the genes associated with the disorder.
Treatment[edit | edit source]
There is no cure for spondylocostal dysplasia, and treatment focuses on managing symptoms and improving quality of life. Interventions may include:
- Orthopedic measures to address spinal curvature, such as bracing or surgery
- Monitoring and support for respiratory function
- Physical therapy to improve mobility and strength
Prognosis[edit | edit source]
The prognosis for individuals with spondylocostal dysplasia varies depending on the severity of the symptoms. Those with milder forms of the condition may have a normal life expectancy and relatively good quality of life, while severe cases, especially those affecting respiratory function, may have more significant health challenges.
See also[edit | edit source]
Spondylocostal dysplasia dominant Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD